Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

ClinicalTrials.gov ID: NCT00339040

Public ClinicalTrials.gov record NCT00339040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age

Study identification

NCT ID
NCT00339040
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
130 participants

Conditions and interventions

Interventions

  • Quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle (VLP) or Quadrivalent human papillomavirus vaccine (QHPV) Biological
  • Placebo/QHPV Other

Biological · Other

Eligibility (public fields only)

Age range
7 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Jul 31, 2009
Completion
Jul 31, 2009
Last update posted
Nov 4, 2021

2006 – 2009

United States locations

U.S. sites
32
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Usc La Nichd Crs Alhambra California 91803
Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach California 90806
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California 90095-1752
Children's Hosp. of Orange County Orange California 92868-3874
UCSD Mother-Child-Adolescent Program CRS San Diego California 92103
Univ. of California San Francisco NICHD CRS San Francisco California 94143
Univ. of Colorado Denver NICHD CRS Aurora Colorado 80045
Connecticut Children's Med. Ctr. Hartford Connecticut 06106
Children's National Med. Ctr. Washington DC NICHD CRS Washington D.C. District of Columbia 20010
Howard Univ. Washington DC NICHD CRS Washington D.C. District of Columbia 20060
South Florida CDTC Ft Lauderdale NICHD CRS Fort Lauderdale Florida 33316
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33136
Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago Illinois 60608
Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago Illinois 60612
Chicago Children's CRS Chicago Illinois 60614
Children's Hosp. New Orleans Louisiana 70118
Children's Hosp. of Boston NICHD CRS Boston Massachusetts 02115
Boston Medical Center Ped. HIV Program NICHD CRS Boston Massachusetts 02118
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01605
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201
Rutgers - New Jersey Medical School CRS Newark New Jersey 07103
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS Brooklyn New York 11203
Nyu Ny Nichd Crs New York New York 10016
Strong Memorial Hospital Rochester NY NICHD CRS Rochester New York 14642
SUNY Stony Brook NICHD CRS Stony Brook New York 11794-8111
Bronx-Lebanon CRS The Bronx New York 10457
Jacobi Med. Ctr. Bronx NICHD CRS The Bronx New York 10461
DUMC Ped. CRS Durham North Carolina 27710
St. Jude/UTHSC CRS Memphis Tennessee 38105
Texas Children's Hosp. CRS Houston Texas 77030
Seattle Children's Hospital CRS Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00339040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00339040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →